Amoxicillin/Dicloxacillin sodium monohydrate

阿莫西林/双氯西林钠

Report date: 2023/02/10 14:28:34
NME

Base Information

Drug NameAmoxicillin/Dicloxacillin sodium monohydrate
Drug Alias Name阿莫西林双氯西林钠
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsYes AmoxicillinDicloxacillin sodium monohydrate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHainan General Sanyang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01C
Related LinksN/A